Thoma Bravo buys into Summa Equity-backed healthcare data business LOGEX

Software-focused private investor Thoma Bravo, has made an investment in LOGEX, a European healthcare analytics provider. LOGEX’s existing shareholders – the company’s founders, and Summa Equity – will remain invested in the business.

LOGEX provides data to help healthcare providers and hospitals make better decisions and deliver optimum health outcomes for patients while reducing costs. Founded in 2008 and headquartered in Amsterdam, LOGEX is currently active in ten countries with the ambition to further expand across Europe.

Jefferies LLC served as exclusive financial advisor to LOGEX and Allen & Overy served as legal counsel. Kirkland & Ellis LLP served as legal counsel to Thoma Bravo and Harris Williams & Co Ltd served as Thoma Bravo’s exclusive financial advisor.

Get the week’s top news delivered directly to your inbox – Sign up for our newsletter

Thoma Bravo is one of the largest private equity firms in the world, with more than $122bn in assets under management as of June 30, 2022. The firm invests in growth-oriented, innovative companies operating in the software and technology sectors.

Leveraging the firm’s deep sector expertise and proven strategic and operational capabilities, Thoma Bravo collaborates with its portfolio companies to implement operating best practices, drive growth initiatives and make accretive acquisitions intended to accelerate revenue and earnings.

Over the past 20 years, the firm has acquired or invested in more than 400 companies representing over $220bn in enterprise value. The firm has offices in Chicago, Miami and San Francisco.

Source: Private Equity Wire

Can’t stop reading? Read more